临床和实验医学杂志
臨床和實驗醫學雜誌
림상화실험의학잡지
JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2015年
9期
723-725
,共3页
姜林鹤%宋云骏%刘运江%黄微%曲雪梅%杨金光
薑林鶴%宋雲駿%劉運江%黃微%麯雪梅%楊金光
강림학%송운준%류운강%황미%곡설매%양금광
结直肠癌%CD133%临床病理特征%预后
結直腸癌%CD133%臨床病理特徵%預後
결직장암%CD133%림상병리특정%예후
Colorectal cancer%CD133%Clinicopathologic features%Prognosis
目的探讨 CD133作为一种癌症干细胞标志物在结直肠癌组织中的表达与结直肠癌临床病理特征的关系及与患者预后的关系。方法利用免疫组化的方法观察 CD133在50例结直肠癌组织中的表达情况,并分析其与患者临床病理特征及预后的关系。结果 CD133在结直肠癌组织的表达明显高于正常黏膜组织( P <0.05),其表达与肿瘤浸润深度、淋巴结转移情况及临床分期有关( P <0.05)。Kaplan - Meier 生存分析,CD133高表达组5年生存率为37.6%,CD133低表达组5年生存率为53.3%,两组间有明显差异( P <0.05)。结论 CD133在结直肠癌组织中高表达并影响结直肠癌患者的预后,其表达水平越高预后越差。
目的探討 CD133作為一種癌癥榦細胞標誌物在結直腸癌組織中的錶達與結直腸癌臨床病理特徵的關繫及與患者預後的關繫。方法利用免疫組化的方法觀察 CD133在50例結直腸癌組織中的錶達情況,併分析其與患者臨床病理特徵及預後的關繫。結果 CD133在結直腸癌組織的錶達明顯高于正常黏膜組織( P <0.05),其錶達與腫瘤浸潤深度、淋巴結轉移情況及臨床分期有關( P <0.05)。Kaplan - Meier 生存分析,CD133高錶達組5年生存率為37.6%,CD133低錶達組5年生存率為53.3%,兩組間有明顯差異( P <0.05)。結論 CD133在結直腸癌組織中高錶達併影響結直腸癌患者的預後,其錶達水平越高預後越差。
목적탐토 CD133작위일충암증간세포표지물재결직장암조직중적표체여결직장암림상병리특정적관계급여환자예후적관계。방법이용면역조화적방법관찰 CD133재50례결직장암조직중적표체정황,병분석기여환자림상병리특정급예후적관계。결과 CD133재결직장암조직적표체명현고우정상점막조직( P <0.05),기표체여종류침윤심도、림파결전이정황급림상분기유관( P <0.05)。Kaplan - Meier 생존분석,CD133고표체조5년생존솔위37.6%,CD133저표체조5년생존솔위53.3%,량조간유명현차이( P <0.05)。결론 CD133재결직장암조직중고표체병영향결직장암환자적예후,기표체수평월고예후월차。
Objective To investigate the expression of cancer stem cell marker CD133 in colorectal cancer tissue and its relevance to the clinicopathologic features and prognosis of colorectal cancer patients. Methods Fifty colorectal cancer patients were investigated in the study. The expression of CD133 in colorectal cancer specimens was detected with immunohistochemistry. The relevance of CD133 expression to the clinico-pathologic features and prognosis of patients was analyzed. Results CD133 expression in cancer tissues was significantly higher than in normal tis-sue( P < 0. 05). The expression of CD133 was related to the depth of invasion of cancer,lymph node metastasis,and clinical stage of the pa-tients( P < 0. 05). Kaplan - Meier survival analysis showed that 5 - year survival rate was higher in CD133 low - expression patients(53. 3% ) than in CD133 high - expression patients(37. 6% )( P < 0. 05). Conclusion CD133 expression is relevant to the prognosis of patients with colorectal cancer. Patients with high - expression of CD133 have poor prognosis.